Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of oral Diosmin to oral Cabergoline in the
prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent
intracytoplasmic sperm injection (ICSI).